Re: In covariate analysis, should we use p-value or OFV to decide which model is better when comparing?
Dear Sumeet,
I assume Pirana is merely running PsN, and you can find good documentation for
each PsN program, in the PsN documentation:
https://uupharmacometrics.github.io/PsN/
https://uupharmacometrics.github.io/PsN/
For this specific question, you should probably not use the gof option and
instead specify p-values for forward and backward selection.
The gof option is only used in special cases, where one does not want to assume
that delta-OFV follows a chi-square distribution (or if one wants to use
p-values lower than 0.00000001).
Best regards
Jakob
Jakob Ribbing, Ph.D.
Senior Consultant, Pharmetheus AB
Cell/Mobile: +46 (0)70 514 33 77
[email protected]
www.pharmetheus.com http://www.pharmetheus.com/
Phone, Office: +46 (0)18 513 328
Uppsala Science Park, Dag Hammarskjölds väg 52B
SE-752 37 Uppsala, Sweden
This communication is confidential and is only intended for the use of the
individual or entity to which it is directed. It may contain information that
is privileged and exempt from disclosure under applicable law. If you are not
the intended recipient please notify us immediately. Please do not copy it or
disclose its contents to any other person.
Quoted reply history
> On 23 Feb 2019, at 21:28, Singla, Sumeet K <[email protected]> wrote:
>
> Dear all,
>
> In step-wise covariate analysis (scm) option in Pirana, there is an -gof
> option in configuration file to let software know whether we should use OFV
> or p-value. My question is, which one we should use while comparing the
> models in scm analysis? P-value or OFV?
>
> Regards,
> Sumeet Singla
> Graduate Student
> Dpt. of Pharmaceutics & Translational Therapeutics
> College of Pharmacy- University of Iowa